Suppr超能文献

所罗门群岛儿童疥疮、皮肤溃疡和血尿的防治:伊维菌素的另一作用

Control of scabies, skin sores and haematuria in children in the Solomon Islands: another role for ivermectin.

作者信息

Lawrence Gregor, Leafasia Judson, Sheridan John, Hills Susan, Wate Janet, Wate Christine, Montgomery Janet, Pandeya Nirmala, Purdie David

机构信息

Australian Centre for International and Tropical Health and Nutrition, Queensland Institute of Medical Research, Post Office, Royal Brisbane Hospital Queensland 4029, Australia.

出版信息

Bull World Health Organ. 2005 Jan;83(1):34-42. Epub 2005 Jan 21.

Abstract

OBJECTIVE

To assess the effects of a 3-year programme aimed at controlling scabies on five small lagoon islands in the Solomon Islands by monitoring scabies, skin sores, streptococcal skin contamination, serology and haematuria in the island children.

METHODS

Control was achieved by treating almost all residents of each island once or twice within 2 weeks with ivermectin (160-250 microg/kg), except for children who weighed less than 15 kg and pregnant women, for whom 5% permethrin cream was used. Reintroduction of scabies was controlled by treating returning residents and visitors, whether or not they had evident scabies.

FINDINGS

Prevalence of scabies dropped from 25% to less than 1% (P < 0.001); prevalence of sores from 40% to 21% (P < 0.001); streptococcal contamination of the fingers in those with and without sores decreased significantly (P = 0.02 and 0.047, respectively) and anti-DNase B levels decreased (P = 0.002). Both the proportion of children with haematuria and its mean level fell (P = 0.002 and P < 0.001, respectively). No adverse effects of the treatments were seen.

CONCLUSION

The results show that ivermectin is an effective and practical agent in the control of scabies and that control reduces the occurrence of streptococcal skin disease and possible signs of renal damage in children. Integrating community-based control of scabies and streptococcal skin disease with planned programmes for controlling filariasis and intestinal nematodes could be both practical and produce great health benefits.

摘要

目的

通过监测所罗门群岛五个小环礁岛上儿童的疥疮、皮肤溃疡、链球菌皮肤感染、血清学和血尿情况,评估一项为期三年的疥疮控制项目的效果。

方法

除体重不足15公斤的儿童和孕妇外,每个岛屿几乎所有居民均在2周内接受一次或两次伊维菌素(160 - 250微克/千克)治疗以实现控制,体重不足15公斤的儿童和孕妇使用5%氯菊酯乳膏治疗。通过治疗返回的居民和访客(无论他们是否有明显疥疮)来控制疥疮的再次传入。

结果

疥疮患病率从25%降至1%以下(P < 0.001);溃疡患病率从40%降至21%(P < 0.001);有溃疡和无溃疡者手指的链球菌感染均显著下降(分别为P = 0.02和0.047),抗脱氧核糖核酸酶B水平下降(P = 0.002)。血尿儿童的比例及其平均水平均下降(分别为P = 0.002和P < 0.001)。未观察到治疗的不良反应。

结论

结果表明伊维菌素是控制疥疮的有效且实用的药物,控制疥疮可减少儿童链球菌性皮肤病的发生以及肾脏损害的可能迹象。将基于社区的疥疮和链球菌性皮肤病控制与控制丝虫病和肠道线虫的计划项目相结合既切实可行又能带来巨大的健康益处。

相似文献

3
[Infantile scabies].
Ann Dermatol Venereol. 2008 Dec;135(12):876-81; quiz 875. doi: 10.1016/j.annder.2008.06.006. Epub 2008 Oct 25.
7
Treatment of scabies: Comparison of permethrin 5% versus ivermectin.
J Dermatol. 2012 Jun;39(6):545-7. doi: 10.1111/j.1346-8138.2011.01481.x. Epub 2012 Mar 5.
8
Treatment of scabies with 5% permethrin cream: results of a German multicenter study.
J Dtsch Dermatol Ges. 2006 May;4(5):407-13. doi: 10.1111/j.1610-0387.2006.05941.x.
9
Management of scabies.
Skin Therapy Lett. 2012 Mar;17(3):1-4.
10
A comparative study of oral ivermectin and topical permethrin cream in the treatment of scabies.
J Am Acad Dermatol. 2000 Feb;42(2 Pt 1):236-40. doi: 10.1016/S0190-9622(00)90131-2.

引用本文的文献

1
Burden of scabies and bacterial skin infection in Kiribati: results of a national population-based survey 2023.
Lancet Reg Health West Pac. 2025 Jul 12;60:101636. doi: 10.1016/j.lanwpc.2025.101636. eCollection 2025 Jul.
3
Ivermectin-Based Mass Drug Administration for Scabies in Northern India: A Single-Arm Community Intervention Trial.
Open Forum Infect Dis. 2024 Oct 1;11(10):ofae573. doi: 10.1093/ofid/ofae573. eCollection 2024 Oct.
4
Secondary Bacterial Infections in Patients with Atopic Dermatitis or Other Common Dermatoses.
Am J Clin Dermatol. 2024 Jul;25(4):623-637. doi: 10.1007/s40257-024-00856-1. Epub 2024 Apr 5.
5
Scabies prevalence after ivermectin-based mass drug administration for lymphatic filariasis, Samoa 2018-2019.
PLoS Negl Trop Dis. 2023 Aug 22;17(8):e0011549. doi: 10.1371/journal.pntd.0011549. eCollection 2023 Aug.
6
Modelling mass drug administration strategies for reducing scabies burden in Monrovia, Liberia.
Epidemiol Infect. 2023 Aug 18;151:e153. doi: 10.1017/S0950268823001310.
7
One versus two doses of ivermectin-based mass drug administration for the control of scabies: A cluster randomised non-inferiority trial.
PLoS Negl Trop Dis. 2023 Mar 17;17(3):e0011207. doi: 10.1371/journal.pntd.0011207. eCollection 2023 Mar.
8
Pharmacokinetic and pharmacodynamic considerations for treating sarcoptic mange with cross-relevance to Australian wildlife.
Int J Parasitol Drugs Drug Resist. 2023 Apr;21:97-113. doi: 10.1016/j.ijpddr.2023.02.004. Epub 2023 Mar 5.
10
Prevention of bacterial complications of scabies using mass drug administration: A population-based, before-after trial in Fiji, 2018-2020.
Lancet Reg Health West Pac. 2022 Mar 22;22:100433. doi: 10.1016/j.lanwpc.2022.100433. eCollection 2022 May.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验